MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/130/0.1/17.01.25 Stock

Warrant

DE000MB8GSJ5

Market Closed - Börse Stuttgart 12:33:24 2024-06-14 pm EDT
0.17 EUR +1.80% Intraday chart for MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/130/0.1/17.01.25
Current month+31.78%
1 month+100.00%
Date Price Change
24-06-14 0.17 +1.80%
24-06-13 0.167 +3.73%
24-06-12 0.161 +5.92%
24-06-11 0.152 +17.83%
24-06-10 0.129 -7.86%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 12:33 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying EDWARDS LIFESCIENCES CORPORATION
Issuer Morgan Stanley
WKN MB8GSJ
ISINDE000MB8GSJ5
Date issued 2023-07-07
Strike 130 $
Maturity 2025-01-17 (217 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.45
Lowest since issue 0.067
Spread 0.01
Spread %5.68%

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Edwards Lifesciences Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.29 USD
Average target price
96.24 USD
Spread / Average Target
+10.25%
Consensus